![Daniel Sharp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Sharp
Direktor/Vorstandsmitglied bei
ALCIDION GROUP LIMITED
Vermögen: 157 832 $ am 31.05.2026
Profil
Mr. Daniel Sharp, CFA, is an Independent Non-Executive Director at Alcidion Group Ltd. He is on the Board of Directors at Botanix Pharmaceuticals Ltd. and Alcidion Group Ltd. Mr. Sharp was previously employed as an Independent Non-ExecutiveDirector by ImpediMed Ltd., an Independent Non-Executive Director by Race Oncology Ltd., an Executive Director by Canaccord Genuity (Australia) Ltd., and an Executive Director by Shaw & Partners Corporate Finance Pty Ltd. He received his undergraduate degree from Monash University and a graduate degree from Monash University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 1’378’572 ( 0.1% ) | 106 633 $ | 31.05.2026 | |
| 20.04.2026 | 2’964’646 ( 0.11% ) | 51 199 $ | 31.05.2026 |
Aktive Positionen von Daniel Sharp
| Unternehmen | Position | Beginn |
|---|---|---|
| ALCIDION GROUP LIMITED | Direktor/Vorstandsmitglied | 01.09.2021 |
| BOTANIX PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 22.03.2022 |
Ehemalige bekannte Positionen von Daniel Sharp
| Unternehmen | Position | Ende |
|---|---|---|
| IMPEDIMED LIMITED | Direktor/Vorstandsmitglied | 28.09.2023 |
| RACURA ONCOLOGY LTD | Direktor/Vorstandsmitglied | 29.06.2023 |
Canaccord Genuity (Australia) Ltd.
 Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Direktor/Vorstandsmitglied | 01.01.2020 |
Shaw & Partners Corporate Finance Pty Ltd.
 Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Ausbildung von Daniel Sharp
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Botanix Pharmaceuticals Ltd.
 Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImpediMed Ltd.
 ImpediMed Ltd. Medical SpecialtiesHealth Technology Develops and distributes medical devices for use clinical assessment and monitoring of human disorders and diseases | Health Technology |
Shaw & Partners Corporate Finance Pty Ltd.
Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Alcidion Group Ltd.
 Alcidion Group Ltd. Packaged SoftwareTechnology Services Develops healthcare software | Technology Services |
Canaccord Genuity (Australia) Ltd.
Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
